165 related articles for article (PubMed ID: 29081976)
1. Oral delivery of curcumin
Chen Q; Si X; Ma L; Ma P; Hou M; Bai S; Wu X; Wan Y; Xiao B; Merlin D
J Mater Chem B; 2017 Aug; 5(29):5881-5891. PubMed ID: 29081976
[TBL] [Abstract][Full Text] [Related]
2. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
[TBL] [Abstract][Full Text] [Related]
4. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
5. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
7. Facile Fabrication of Oxidation-Responsive Polymeric Nanoparticles for Effective Anticancer Drug Delivery.
Huang Y; Chen Q; Ma P; Song H; Ma X; Ma Y; Zhou X; Gou S; Xu Z; Chen J; Xiao B
Mol Pharm; 2019 Jan; 16(1):49-59. PubMed ID: 30485109
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
9. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue.
Chen Q; Gou S; Huang Y; Zhou X; Li Q; Han MK; Kang Y; Xiao B
Colloids Surf B Biointerfaces; 2018 Sep; 169():92-98. PubMed ID: 29751345
[TBL] [Abstract][Full Text] [Related]
10. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
11. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
[TBL] [Abstract][Full Text] [Related]
12. Porous Polymeric Microparticles as an Oral Drug Platform for Effective Ulcerative Colitis Treatment.
Zhou X; Chen Q; Ma Y; Huang Y; Gou S; Xiao B
J Pharm Sci; 2019 Jul; 108(7):2238-2242. PubMed ID: 30779888
[TBL] [Abstract][Full Text] [Related]
13. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
15. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
16. Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery.
He P; Tang B; Li Y; Zhang Y; Liu X; Guo X; Wang D; She P; Xiao C
Int J Nanomedicine; 2021; 16():5053-5064. PubMed ID: 34349508
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
19. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis.
Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F
Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
